Bangalore Genei's leadership in academic segment expects to boost Merck's bio business in India

Pharmaceutical manufacturing, especially in the more chemical effluents creating bulk drug production plants in India may become environment-friendly soon.

Geron and Merck are currently testing drugs targetting telomerase enzyme

Biocon believes its oral insulin pill IN-105 has the potential to become a multibillion dollar blockbuster

Danish pharma company Novo Nordisk A/S is planning to increase staff strength in India upto 500 employees in the next few years.

Drug manufacturers with valid product licences issued by state authorities can use them till expiry

Natco Pharma has priced Natflu -its version of H1N1 swineflu drug oseltmivir - meant for government supply at Rs 275 per dose, triggering a possible selling price battle among the Indian companies who make Tamiflu generics.

India plans to introduce pentavalent vaccines initially in Himachal Pradesh, Jammu and Kashmir, Karnataka, Kerala and Tamil Nadu

India's leading generic player Cipla Ltd is planning to raise up to Rs 1500 crore or $175 million by selling shares to institutional investors, reports said.

  Multinational companies operating in India will control nearly 8-10 per cent of the total market with their patented medicine worth $8 billion in the domestic pharmaceutical market by 2015, according to a new survey findings from FICCI-Ernst & Young Report on Compelling Reasons for Doing Clinical Research in India.